• 7018 Citations
  • 41 h-Index
1986 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Antonella Castagna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 51 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
CD4 Lymphocyte Count Medicine & Life Sciences
Acquired Immunodeficiency Syndrome Medicine & Life Sciences
RNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

  • 7018 Citations
  • 41 h-Index
  • 296 Article
  • 2 Letter
3 Citations (Scopus)

Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): Data from a real-life setting

Monforte, A. D. A., Cozzi-Lepri, A., Di Biagio, A., Marchetti, G., Lo Caputo, S., Rusconi, S., Gianotti, N., Mazzotta, V., Mazzarello, G., Costantini, A., Castagna, A. & Antinori, A., Jan 1 2019, In : Journal of Antimicrobial Chemotherapy. 74, 5, p. 1363-1367 5 p.

Research output: Contribution to journalArticle

Treatment Failure
CD4 Lymphocyte Count
Hepatitis C
Cohort Studies
2 Citations (Scopus)

LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples

Ferrari, D., Ripa, M., Premaschi, S., Banfi, G., Castagna, A. & Locatelli, M., May 30 2019, In : Journal of Pharmaceutical and Biomedical Analysis. 169, p. 11-18 8 p.

Research output: Contribution to journalArticle

Plasma (human)
Viral Load
Reverse Transcriptase Inhibitors
Cardiovascular Diseases

Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen

ICONA Foundation Study group, Jan 1 2019, In : Antiviral Therapy. 24, 5, p. 321-331 11 p.

Research output: Contribution to journalArticle